Search research articles
Contact Us
Filters
Showing results (1-10 of 49) with videos related to
Page
of 5
Sort By:
Chemistry & Biology
|
October 21, 2006
Small-molecule compounds that modulate lipolysis in adipose tissue: targeting strategies and molecular classes
Minghan Wang, Christopher Fotsch
Journal of Medicinal Chemistry
|
July 26, 2008
Blockade of glucocorticoid excess at the tissue level: inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 as a therapy for type 2 diabetes
Christopher Fotsch, Minghan Wang
Current Medicinal Chemistry
|
January 29, 2008
Calcium sensing receptor activators: calcimimetics
Paul E Harrington, Christopher Fotsch
Journal of Medicinal Chemistry
|
April 27, 2012
Mitigating heterocycle metabolism in drug discovery
David J St Jean, Christopher Fotsch
Journal of Medicinal Chemistry
|
March 12, 2010
Emerging targets in osteoporosis disease modification
John G Allen, Christopher Fotsch, Philip Babij
Current Topics in Medicinal Chemistry
|
December 17, 2008
Inhibitors of 11beta-HSD1: a potential treatment for the metabolic syndrome
David J St Jean, Minghan Wang, Christopher Fotsch
Bioorganic & Medicinal Chemistry Letters
|
December 31, 2003
Synthesis of novel melanocortin 4 receptor agonists and antagonists containing a succinamide core
Ning Xi, Clarence Hale, Michael G Kelly, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 20, 2007
Piperidine amides as 11beta-hydroxysteroid dehydrogenase type 1 inhibitors
Katarina Flyrén, Lars O Bergquist, Victor M Castro, et al.
Journal of Medicinal Chemistry
|
November 19, 2015
Systematic Study of the Glutathione (GSH) Reactivity of N-Arylacrylamides: 1. Effects of Aryl Substitution
Victor J Cee, Laurie P Volak, Yuping Chen, et al.
Journal of Medicinal Chemistry
|
September 23, 2020
Systematic Study of the Glutathione Reactivity of <i>N</i>-Phenylacrylamides: 2. Effects of Acrylamide Substitution
Adam Birkholz, David J Kopecky, Laurie P Volak, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 49) with videos related to
Sort By:
Page
of 5
Chemistry & Biology
|
October 21, 2006
Small-molecule compounds that modulate lipolysis in adipose tissue: targeting strategies and molecular classes
Minghan Wang, Christopher Fotsch
Journal of Medicinal Chemistry
|
July 26, 2008
Blockade of glucocorticoid excess at the tissue level: inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 as a therapy for type 2 diabetes
Christopher Fotsch, Minghan Wang
Current Medicinal Chemistry
|
January 29, 2008
Calcium sensing receptor activators: calcimimetics
Paul E Harrington, Christopher Fotsch
Journal of Medicinal Chemistry
|
April 27, 2012
Mitigating heterocycle metabolism in drug discovery
David J St Jean, Christopher Fotsch
Journal of Medicinal Chemistry
|
March 12, 2010
Emerging targets in osteoporosis disease modification
John G Allen, Christopher Fotsch, Philip Babij
Current Topics in Medicinal Chemistry
|
December 17, 2008
Inhibitors of 11beta-HSD1: a potential treatment for the metabolic syndrome
David J St Jean, Minghan Wang, Christopher Fotsch
Bioorganic & Medicinal Chemistry Letters
|
December 31, 2003
Synthesis of novel melanocortin 4 receptor agonists and antagonists containing a succinamide core
Ning Xi, Clarence Hale, Michael G Kelly, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 20, 2007
Piperidine amides as 11beta-hydroxysteroid dehydrogenase type 1 inhibitors
Katarina Flyrén, Lars O Bergquist, Victor M Castro, et al.
Journal of Medicinal Chemistry
|
November 19, 2015
Systematic Study of the Glutathione (GSH) Reactivity of N-Arylacrylamides: 1. Effects of Aryl Substitution
Victor J Cee, Laurie P Volak, Yuping Chen, et al.
Journal of Medicinal Chemistry
|
September 23, 2020
Systematic Study of the Glutathione Reactivity of <i>N</i>-Phenylacrylamides: 2. Effects of Acrylamide Substitution
Adam Birkholz, David J Kopecky, Laurie P Volak, et al.
Page
of 5